With tremendous amounts of data being generated around even a single medical condition, there are many opportunities to catch new trends, targets and threats. Our insights help pharmaceutical brands stay on top of it all to make key decisions across the drug development lifecycle, leveraging and connecting a wide range of external data sources to track developments across all therapeutic conditions and more than 1600+ rare diseases. Our platform speeds the time to insight and lessens the load on researchers looking for actionable intelligence.
Prioritize business development, licensing, and M&A opportunities by scientific and technical merit.
Tap into diverse data sets to inform short and long-term strategies across therapeutic areas.
Harmonize disparate data sets and connect insights to business objectives in a single platform.
Turn external data into winning drug development strategies that will help you to optimize your portfolio, accelerate your pipeline, and propel new areas of innovation.
From pipeline to market, Signals Analytics puts you in the driver seat, increasing your chances of success with actionable insights on pharmaceutical targets and modalities.
With patented NLP and AI technologies, we provide relevant and actionable insights to help improve asset value and evaluate the potential success of a potential asset.
The Signals Analytics platform dynamically assesses the target landscape, helping pharmaceutical companies, emerging biotechs and research organizations fast track the time it takes to identify lucrative drug development opportunities.
We continuously refresh our data, allowing for fast and timely detection of new capabilities and drug effects that can impact M&A strategies.
"The ability of AI to fuel drug development for complex conditions and rare diseases and drive commercial success makes platforms like Signals Analytics critical for managing business lifecycle decisions."
Are you looking for a next-generation advanced analytics platform that can help uncover trends and insights?